Table 2.

Baseline patient cardiac intervention history and drug regimens.

	EECP (n = 10) (8 male, 2 female)	Sham (n = 7) (5 male, 2 female)
Prior CABG	7 (70)	6 (86)
Prior PTCA	7 (70)	5 (67)
Prior Myocardial Infarction	5 (50)	4 (56)
Multivessel CAD	9 (90)	6 (89)
Diabetes Mellitus	5 (50)	3 (43)
Hypertension	9 (90)	6 (86)
Hyperlipidemia	9 (90)	6 (86)
Lipid-lowering drug	9 (90)	6 (86)
β-blocker	8 (80)	6 (86)
Calcium channel blocker	3 (30)	2 (22)
Long-lasting nitrates	8 (80)	5 (78)
ACE inhibition or ARB	9 (90)	6 (86)
Insulin	2 (20)	2 (22)

Values are presented as the number of patients per group and the percentage within each group (in parentheses). There were no significant differences (P>0.05) in baseline characteristics, drug regimens, and cardiac intervention history between CAD and LVD groups at baseline. CAD indicates coronary artery disease with normal left ventricular function; LVD, left ventricular dysfunction (ejection fraction <40%, but >30%); CABG, coronary artery bypass graft; PTCA, percutaneous transluminal coronary angioplasty; ACE, angiotensin-converting enzyme; and ARB, angiotensin receptor blocker.